Healthcare provider profile · identity verified

Daniel M Addis, MD, DO

Family Practice · DANVILLE, VA · NPI 1144249400

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Rosuvastatin Calcium	Rosuvastatin Calcium	610	175
Amlodipine Besylate	Amlodipine Besylate	530	146
Atorvastatin Calcium	Atorvastatin Calcium	452	128
Metformin Hcl	Metformin Hcl	422	126
Lisinopril	Lisinopril	361	98
Levothyroxine Sodium	Levothyroxine Sodium	342	85
Omeprazole	Omeprazole	266	84
Metoprolol Succinate	Metoprolol Succinate	242	63
Losartan Potassium	Losartan Potassium	232	63
Escitalopram Oxalate	Escitalopram Oxalate	219	75
Hydrochlorothiazide	Hydrochlorothiazide	217	61
Farxiga	Dapagliflozin Propanediol	212	55
Hydralazine Hcl	Hydralazine Hcl	197	59
Tamsulosin Hcl	Tamsulosin Hcl	190	63
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	183	41
Glimepiride	Glimepiride	165	48
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	161	57
Ozempic	Semaglutide	161	34
Simvastatin	Simvastatin	158	43
Tresiba Flextouch U-100	Insulin Degludec	150	40
Allopurinol	Allopurinol	137	33
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	137	37
Prednisone	Prednisone	137	98
Valsartan	Valsartan	137	39
Pravastatin Sodium	Pravastatin Sodium	122	33
Metoprolol Tartrate	Metoprolol Tartrate	120	36
Clopidogrel	Clopidogrel Bisulfate	118	31
Olmesartan Medoxomil	Olmesartan Medoxomil	117	38
Carvedilol	Carvedilol	115	38
Furosemide	Furosemide	110	46
Azithromycin	Azithromycin	108	88
Citalopram Hbr	Citalopram Hydrobromide	103	23
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	102	36
Gabapentin	Gabapentin	99	43
Chlorthalidone	Chlorthalidone	96	26
Naproxen	Naproxen	93	42
Eliquis	Apixaban	90	26
Tresiba Flextouch U-200	Insulin Degludec	88	22
Janumet	Sitagliptin Phos/Metformin Hcl	71	16
Albuterol Sulfate Hfa	Albuterol Sulfate	69	25
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	68	26
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	67	18
Duloxetine Hcl	Duloxetine Hcl	66	20
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	62	15
Pantoprazole Sodium	Pantoprazole Sodium	59	18
Jardiance	Empagliflozin	55	13
Spironolactone	Spironolactone	55	17
Xarelto	Rivaroxaban	51	suppressed
Montelukast Sodium	Montelukast Sodium	49	14
Toujeo Max Solostar	Insulin Glargine,hum.Rec.Anlog	48	14
Finasteride	Finasteride	45	16
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	45	17
Trazodone Hcl	Trazodone Hcl	45	18
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	41	28
Janumet Xr	Sitagliptin Phos/Metformin Hcl	40	14
Synthroid	Levothyroxine Sodium	40	suppressed
Tramadol Hcl	Tramadol Hcl	39	17
Atenolol	Atenolol	37	12
Azelastine Hcl	Azelastine Hcl	35	17
Potassium Chloride	Potassium Chloride	35	14
Labetalol Hcl	Labetalol Hcl	34	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	32	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	32	23
Meloxicam	Meloxicam	31	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	30	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	29	suppressed
Donepezil Hcl	Donepezil Hcl	29	11
Dropsafe Prep Pads	Alcohol Antiseptic Pads	28	11
Fluticasone Propionate	Fluticasone Propionate	28	suppressed
Trulicity	Dulaglutide	28	suppressed
Famotidine	Famotidine	27	suppressed
Enalapril Maleate	Enalapril Maleate	26	suppressed
Levemir Flexpen	Insulin Detemir	26	suppressed
Methimazole	Methimazole	25	suppressed
Sertraline Hcl	Sertraline Hcl	24	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	23	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	23	suppressed
Glipizide	Glipizide	23	suppressed
Telmisartan-Hydrochlorothiazid	Telmisartan/Hydrochlorothiazid	23	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	23	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	23	11
Droplet Pen Needle	Pen Needle, Diabetic	22	suppressed
Januvia	Sitagliptin Phosphate	22	suppressed
Ropinirole Hcl	Ropinirole Hcl	22	suppressed
Telmisartan	Telmisartan	21	suppressed
Bupropion Hcl Sr	Bupropion Hcl	20	suppressed
Novolog Flexpen	Insulin Aspart	20	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	20	suppressed
Benazepril Hcl	Benazepril Hcl	19	suppressed
Diclofenac Sodium	Diclofenac Sodium	19	suppressed
Linzess	Linaclotide	19	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	18	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	18	suppressed
Klor-Con M20	Potassium Chloride	18	suppressed
Alprazolam	Alprazolam	17	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	17	17
Humalog Kwikpen U-100	Insulin Lispro	17	suppressed
Pregabalin	Pregabalin	17	suppressed
Alendronate Sodium	Alendronate Sodium	15	suppressed
Baclofen	Baclofen	15	suppressed
Colchicine	Colchicine	15	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	15	15
Paroxetine Hcl	Paroxetine Hcl	15	suppressed
Topiramate	Topiramate	15	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	14	14
Doxazosin Mesylate	Doxazosin Mesylate	14	suppressed
Humalog Mix 75-25 Kwikpen	Insulin Lispro Protamin/Lispro	14	suppressed
Isosorbide Dinitrate	Isosorbide Dinitrate	14	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	14	suppressed
Novolin 70-30	Insulin Nph Hum/Reg Insulin Hm	14	suppressed
Amantadine	Amantadine Hcl	13	suppressed
Novolog Mix 70-30 Flexpen	Insulin Aspart Prot/Insuln Asp	13	suppressed
Propranolol Hcl Er	Propranolol Hcl	13	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	13	12
Cephalexin	Cephalexin	12	12
Jentadueto	Linagliptin/Metformin Hcl	12	suppressed
Tradjenta	Linagliptin	12	suppressed
Triazolam	Triazolam	12	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error